NAFDAC Approves Pfizer-BioTech COVID-19 Vaccine For Use In Nigeria
NAFDAC has approved the use of Pfizer COVID-19 vaccine in Nigeria.
Joy Kalu 
The National Agency for Food and Drug Administration and Control, NAFDAC, on Friday approved the use of Pfizer COVID-19 vaccine in Nigeria.
This is coming few months after it gave authorisation for the use of the Oxford-Astrazeneca jabs in the country.
Announcing this at a press conference in Lagos, the Director-General of NAFDAC, Mojisola Adeyeye explained that the Pfizer-Bio-Tech vaccine was for emergency use only.
She added that the vaccine can now be stored between -15 to-25 equivalent to freezer temperature.
National Agency for Food and Drug Administration and Control has been preparing for the COVID-19 vaccines and vaccination since the early phase of the pandemic – around April 2020.
NAFDAC was positioned to a great extent to work online during the lockdown due to digitalization of many of our processes and continuous improvement.
